Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

Summary

This trial is a single arm, open phase I clinical study to investigate the safety and efficacy of personalized KSX01-TCRT in patients with advanced solid tumors. This experiment is divided into two parts: the dose increasing stage (Part A) and the dose expanding stage (Part B). For those enrolled in the planned expansion phase, the dose should have passed the safety assessment during the dose escalation phase.

Timeline

Start

2023-11-07

Primary completion

2026-12-01

Completion

2028-12-01

Drugs

Indications